https://www.selleckchem.com/pr....oducts/Clofarabine.h
02 - 103.11% and 98.19 - 102.06%, respectively. This single-dose study has shown that the test and reference favipiravir products met the required bioequivalence criteria. Besides, both products were well tolerated and safe. This single-dose study has shown that the test and reference favipiravir products met the required bioequivalence criteria. Besides, both products were well tolerated and safe. This study aimed to evaluate the antiviral efficacy of lopinavir-ritonavir alone or combined with arbidol in the treatment of hospitaliz
Suka
Komentar
Membagikan
